Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Nintendo: Game On!
Parul Purwar; Andrew Karl DeliosCaso IVEY-9B16M158-EDirección estratégicaIn 2015, Nintendo—the iconic Japanese video game company—was faced with the decade-long challenge of responding to an industry that had changed in ways it had not anticipated. Under its new president, Nintendo had to contend with large-scale changes in the global gaming market. By not adapting to changing customer needs, Nintendo had lost the customer loyalty it had once enjoyed, as was evident from the decline in the number of units sold. It fac...Desde 8,20 €
-
Pokémon GO: Game On!
Parul Purwar; Andrew Karl DeliosCaso IVEY-9B16M187-EDirección estratégicaThis case is a supplement to Nintendo: Game On! Released in July 2016, Pokémon GO was a location-based virtual reality mobile game in which players needed to locate and capture virtual creatures from the Pokémon family. Although it was a revolutionary concept, would its release mark a change in Nintendo’s recent history of continuous decline in revenues and profits? Supplement for product 9B16M158.Desde 8,20 €
-
The Healthcare and Pharmaceutical Industries in China
Andrew Karl Delios; Parul PurwarCaso IVEY-9B16M226-EDirección estratégicaThis industry note details the state of the healthcare and pharmaceutical industries in China in 2012. It has details on the size of the respective industries, their growth, their regulation and key political actors, as well as information and analysis on other important stakeholders in the pharmaceutical and health care sectors in China in the 2010s. The level of detail is high, as is the complexity of information presented. The note can be used...Desde 8,20 €
-
AdNike Pharmaceuticals: A Foreign CEO in China
Parul Purwar; Andrew Karl DeliosCaso IVEY-9B16M225-EDirección estratégicaIn 2012, the incoming general manager for AdNike Pharmaceutical’s operations in China faced a major challenge. AdNike was a leading global pharmaceutical company that had been in China for over 40 years. However, its performance in the country had been worse than expected. In the most recent half-decade of its operations in China, AdNike faced a changing regulatory environment that was becoming more challenging to navigate. Also, local competitor...Desde 8,20 €